Combination of urinary fibrinogen β-chain and tyrosine-phosphorylated proteins for the detection of bladder cancer

被引:1
作者
Giribaldi, Giuliana [1 ]
Filippini, Claudia [2 ]
Viberti, Clara [3 ]
Khadjavi, Amina [1 ]
Finesso, Nicole [1 ]
Ulliers, Daniela [1 ]
Turini, Stefano [4 ]
Bressan, Bruno Emilio [1 ]
Pecoraro, Francesca [1 ]
Prato, Mauro [4 ]
Allione, Alessandra [3 ]
Bellis, Matteo De [5 ]
Montefusco, Gabriele [5 ]
Bonomessi, Giulia [5 ]
Allasia, Marco [5 ]
Matullo, Giuseppe [3 ,6 ]
Soria, Francesco [5 ]
Gontero, Paolo [5 ]
机构
[1] Univ Turin, Dept Oncol, Turin, Italy
[2] Univ Turin, Dept Surg Sci, Turin, Italy
[3] Univ Turin, Dept Med Sci, Turin, Italy
[4] Univ Turin, Dept Neurosci, Turin, Italy
[5] Torino Sch Med, AOU Citta & Salute Sci, Dept Surg Sci, Div Urol, Turin, Italy
[6] AOU Citta Salute & Sci, SC Med Genet, Turin, Italy
来源
FUTURE SCIENCE OA | 2021年 / 7卷 / 09期
关键词
bladder cancer; fibrinogen beta-chain; tyrosine-phosphorylated proteins; urinary markers; MARKERS;
D O I
10.2144/fsoa-2021-0060
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aim: to evaluate the performance of urinary fibrinogen beta-chain (FBC) - either alone or associated with urinary tyrosine-phosphorylated proteins (UPY) - as bladder cancer (BCa) diagnostic biomarker. Materials & methods: 164 subjects were tested. Results: significantly different FBC and UPY levels were found between BCa patients and controls, as well as between low-grade and high-grade cancers. The diagnostic accuracy was 0.84 for FBC and 0.87 for UPY. The combination of FBC and UPY improved the accuracy to 0.91. The addition of clinical variables (age, gender, and smoking habit) to FBC and UPY into a model for BCa prediction significantly improved the accuracy to 0.99. The combination of FBC and UPY adjusted for clinical variables associates with the highest sensitivity and good specificity. Conclusion: urinary FBC and UPY could be used as biomarkers for BCa diagnosis.
引用
收藏
页数:10
相关论文
共 24 条
[1]   Role of coagulation factors in urological malignancy: A prospective, controlled study on prostate, renal and bladder cancer [J].
Alevizopoulos, Aristeidis ;
Tyritzis, Stavros ;
Leotsakos, Ioannis ;
Anastasopoulou, Ioanna ;
Pournaras, Christos ;
Kotsis, Paraskevi ;
Katsarou, Olga ;
Alamanis, Christos ;
Stravodimos, Konstantinos ;
Constantinides, Constantinos .
INTERNATIONAL JOURNAL OF UROLOGY, 2017, 24 (02) :130-136
[2]   MMP23B expression and protein levels in blood and urine are associated with bladder cancer [J].
Allione, Alessandra ;
Pardini, Barbara ;
Viberti, Clara ;
Giribaldi, Giuliana ;
Turini, Stefano ;
Di Gaetano, Cornelia ;
Guarrera, Simonetta ;
Cordero, Francesca ;
Oderda, Marco ;
Allasia, Marco ;
Gontero, Paolo ;
Sacerdote, Carlotta ;
Vineis, Paolo ;
Matullo, Giuseppe .
CARCINOGENESIS, 2018, 39 (10) :1254-1263
[3]   European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update [J].
Babjuk, Marko ;
Burger, Maximilian ;
Comperat, Eva M. ;
Gontero, Paolo ;
Mostafid, A. Hugh ;
Palou, Joan ;
van Rhijn, Bas W. G. ;
Roupret, Morgan ;
Shariat, Shahrokh F. ;
Sylvester, Richard ;
Zigeuner, Richard ;
Capoun, Otakar ;
Cohen, Daniel ;
Dominguez Escrig, Jose Luis ;
Hernandez, Virginia ;
Peyronnet, Benoit ;
Seisen, Thomas ;
Soukup, Viktor .
EUROPEAN UROLOGY, 2019, 76 (05) :639-657
[4]   A COMMUNITY STUDY OF BLADDER-CANCER SCREENING BY THE DETECTION OF OCCULT URINARY BLEEDING [J].
BRITTON, JP ;
DOWELL, AC ;
WHELAN, P ;
HARRIS, CM .
JOURNAL OF UROLOGY, 1992, 148 (03) :788-790
[5]   Absolute basophil count is associated with time to recurrence in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Guerin after transurethral resection of the bladder tumor [J].
Ferro, M. ;
Di Lorenzo, G. ;
Vartolomei, M. D. ;
Bruzzese, D. ;
Cantiello, F. ;
Lucarelli, G. ;
Musi, G. ;
Di Stasi, S. ;
Hurle, R. ;
Guazzoni, G. ;
Busetto, G. M. ;
Gabriele, A. ;
Del Giudice, F. ;
Damiano, R. ;
Perri, F. ;
Perdona, S. ;
Verze, P. ;
Borghesi, M. ;
Schiavina, R. ;
Almeida, G. L. ;
Bove, P. ;
Lima, E. ;
Autorino, R. ;
Crisan, N. ;
Abu Farhan, A. R. ;
Battaglia, M. ;
Russo, G. I. ;
Ieluzzi, Vincenzo ;
Morgia, G. ;
De Placido, P. ;
Terracciano, D. ;
Cimmino, A. ;
Scafuri, L. ;
Mirone, V. ;
De Cobelli, O. ;
Shariat, S. ;
Sonpavde, Guru ;
Buonerba, C. .
WORLD JOURNAL OF UROLOGY, 2020, 38 (01) :143-150
[6]   Systemic combining inflammatory score (SCIS): a new score for prediction of oncologic outcomes in patients with high-risk non-muscle-invasive urothelial bladder cancer [J].
Ferro, Matteo ;
Di Mauro, Marina ;
Cimino, Sebastiano ;
Morgia, Giuseppe ;
Lucarelli, Giuseppe ;
Abu Farhan, Abdal Rahman ;
Vartolomei, Mihai Dorin ;
Porreca, Angelo ;
Cantiello, Francesco ;
Damiano, Rocco ;
Busetto, Gian Maria ;
Del Giudice, Francesco ;
Hurle, Rodolfo ;
Perdona, Sisto ;
Borghesi, Marco ;
Bove, Pierluigi ;
Autorino, Riccardo ;
Crisan, Nicolae ;
Marchioni, Michele ;
Schips, Luigi ;
Soria, Francesco ;
Mari, Andrea ;
Minervini, Andrea ;
Veccia, Alessandro ;
Battaglia, Michele ;
Terracciano, Daniela ;
Musi, Gennaro ;
Cordima, Giovanni ;
Muto, Matteo ;
Mirone, Vincenzo ;
de Cobelli, Ottavio ;
Russo, Giorgio Ivan .
TRANSLATIONAL ANDROLOGY AND UROLOGY, 2021, 10 (02) :626-+
[7]   An increased body mass index is associated with a worse prognosis in patients administered BCG immunotherapy for T1 bladder cancer [J].
Ferro, Matteo ;
Vartolomei, Mihai Dorin ;
Russo, Giorgio Ivan ;
Cantiello, Francesco ;
Abu Farhan, Abdal Rahman ;
Terracciano, Daniela ;
Cimmino, Amelia ;
Di Stasi, Savino ;
Musi, Gennaro ;
Hurle, Rodolfo ;
Serretta, Vincenzo ;
Busetto, Gian Maria ;
De Berardinis, Ettore ;
Cioffi, Antonio ;
Perdona, Sisto ;
Borghesi, Marco ;
Schiavina, Riccardo ;
Cozzi, Gabriele ;
Almeida, Gilberto L. ;
Bove, Pierluigi ;
Lima, Estevao ;
Grimaldi, Giovanni ;
Matei, Deliu Victor ;
Crisan, Nicolae ;
Muto, Matteo ;
Verze, Paolo ;
Battaglia, Michele ;
Guazzoni, Giorgio ;
Autorino, Riccardo ;
Morgia, Giuseppe ;
Damiano, Rocco ;
de Cobelli, Ottavio ;
Shariat, Shahrokh ;
Mirone, Vincenzo ;
Lucarelli, Giuseppe .
WORLD JOURNAL OF UROLOGY, 2019, 37 (03) :507-514
[8]   Role of the Coagulation System in Genitourinary Cancers: Review [J].
John, Axel ;
Gorzelanny, Christian ;
Bauer, Alexander T. ;
Schneider, Stefan W. ;
Bolenz, Christian .
CLINICAL GENITOURINARY CANCER, 2018, 16 (01) :E29-E37
[9]   Performance Characteristics of a Multigene Urine Biomarker Test for Monitoring for Recurrent Urothelial Carcinoma in a Multicenter Study [J].
Kavalieris, Laimonis ;
O'Sullivan, Paul ;
Frampton, Chris ;
Guilford, Parry ;
Darling, David ;
Jacobson, Elsie ;
Suttie, James ;
Raman, Jay D. ;
Shariat, Shahrokh F. ;
Lotan, Yair .
JOURNAL OF UROLOGY, 2017, 197 (06) :1419-1425
[10]   Early diagnosis of bladder cancer through the detection of urinary tyrosine-phosphorylated proteins [J].
Khadjavi, A. ;
Mannu, F. ;
Destefanis, P. ;
Sacerdote, C. ;
Battaglia, A. ;
Allasia, M. ;
Fontana, D. ;
Frea, B. ;
Polidoro, S. ;
Fiorito, G. ;
Matullo, G. ;
Pantaleo, A. ;
Notarpietro, A. ;
Prato, M. ;
Castagno, F. ;
Vineis, P. ;
Gontero, P. ;
Giribaldi, G. ;
Turrini, F. .
BRITISH JOURNAL OF CANCER, 2015, 113 (03) :469-475